Synthesis of JAK2 Inhibitor BMS-911543
Significance: BMS-911543 is a selective JAK2 kinase inhibitor that is of interest for the treatment of myeloproliferative disorders. The key step in the synthesis depicted is the nickel-mediated cyclization (B → F) that enabled the construction of the highly functionalized 1H-pyrrolo [2,3-b] pyridine core in just eight steps (29% overall yield) from ethyl 4-bromo-1H-pyrrole-2-carboxylate.
Comment:
The final amide bond formation was complex owing to the instability of dicyclopropylamine (DCPA). After screening a variety of more unusual conditions, 2-chloro-1,3-dimethylimidazolidinium chloride (J) cleanly and quantitatively formed the acid chloride of carboxylate I which smoothly coupled with DCPA. 
